NervGen Pharma Return on Net Operating Assets Trends

NervGen Pharma Corp. (NGEN)

2.07 -0.01 (-0.48%) USD | NASDAQ | May 29, 16:00

2.06 -0.01 (-0.48%) After-Hours: 20:00

View Return on Net Operating Assets for NGEN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

InMed Pharmaceuticals, Inc.	Upgrade
Milestone Pharmaceuticals, Inc.	Upgrade
Manzo Pharmaceuticals, Inc.	--
Clearmind Medicine, Inc.	Upgrade
Pharmagreen Biotech, Inc.	Upgrade